The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Inv Regulatory News (BRH)

Share Price Information for Braveheart Inv (BRH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.50
Bid: 6.00
Ask: 7.00
Change: 0.00 (0.00%)
Spread: 1.00 (16.667%)
Open: 6.50
High: 6.50
Low: 6.50
Prev. Close: 6.50
BRH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity and Directorate Change

25 Mar 2014 07:00

RNS Number : 0542D
Braveheart Investment Group plc
25 March 2014
 



 

25 March 2014

Braveheart Investment Group plc

('Braveheart', the 'Company' or the 'Group')

Appointment of Non-executive Director

Subscription raising £250,000

Braveheart Investment Group plc, the AIM-listed investment management group providing financing to SMEs, servicing the investment requirements of business angels, high net worth individuals, family offices and public sector organisations, and directly holding an investment portfolio of early-stage technology companies, is pleased to announce the appointment of Trevor Brown to the Board of the Company and a subscription by Mr Brown raising approximately £250,000.

Board Appointment

The Company is pleased to announce the appointment of Trevor Brown to the Board of the Company as a Non-executive Director with effect from 1 April 2014. Mr Brown, aged 67, has been a strategic investor in equities and real estate for more than 30 years. He is currently a Non-executive Director of Feedback plc and was until recently a director of Advanced Oncotherapy plc where he was involved in the strategy of transition to the provision of advanced cancer treatment services.

Subscription

The Company is also pleased to announce that it has raised approximately £250,000 through the issue of 2,283,855 new ordinary shares of 2p each in the capital of the Company at a subscription price of 10.9464p per share ("Subscription Shares") to Mr Brown. The subscription price of 10.9464p per share is equal to the volume weighted average share price for the Company for the period 1 January 2014 to 28 February 2014.

Application will be made to the London Stock Exchange for the Subscription Shares to be admitted to trading on AIM and it is expected that admission will become effective and that dealings in the Subscription Shares will commence on 28 March 2014. Following the issue of the Subscription Shares, the Company will have 25,870,491 ordinary voting shares in issue.

Mr Brown is currently beneficially interested in 250,000 ordinary shares of the Company, representing 1.06% of the current issued share capital. Following admission of the Subscription Shares, Mr Brown will be beneficially interested in 2,533,855 ordinary shares of the Company, representing 9.79% of the issued share capital.

Geoffrey Thomson, Chief Executive of Braveheart, said:

"We are delighted to welcome Trevor to the Board and also with the support he has shown the Company through his subscription.

"His expertise will help unlock value in the business and the Board is now back to full strength following the retirement of Edward Cunningham late last year."

The following information is also required to be disclosed in accordance with Rule 17 and Schedule 2 paragraph (g) of the AIM Rules for Companies.

Mr Trevor Edward Brown, aged 67:

Current directorships:

Past directorships held in the past 5 years:

Free Association Books Limited

Advanced Oncotherapy plc

Free Publishing Limited

 

Feedback plc

 

 

Further information:

Braveheart Investment Group plc

Geoffrey Thomson, Chief Executive Tel: +44 1738 587555

gthomson@braveheartgroup.co.uk

 

Sanlam Securities UK Limited (Nominated Advisor and Broker to Braveheart)

Lindsay Mair Tel: +44 20 7628 2200

Catherine Miles

 

Media Enquiries (Braveheart):

Allerton Communications

Peter Curtain Tel: +44 20 3137 2500

peter.curtain@allertoncomms.co.uk

 

Notes to Editors

 

Braveheart Investment Group plc

 

Braveheart provides financing and associated advisory services for small and medium sized enterprises (SMEs) as follows:

 

For the company looking to raise money, we provide:

· Equity Capital. This form of financing is typically long term and is usually appropriate for fast growing business or early stage companies. We will consider equity financings where our individual investment, or the investment we arrange, would normally be a maximum or £2m although we are happy to participate in larger financings as part of a syndicate;

· Debt Finance. Short to medium term and for companies with cash flow to service the loan. Our unit size for this type of finance is up to £1m and we will usually provide junior debt which is unsecured but linked to an equity instrument;

 

The money we invest comes from a variety of sources (see below) and is sometimes linked to particular geographical locations.

 

To the investor, we provide a one-stop shop service to those in one of the following groups who are looking for exposure to SME investments:

· High Net Worth (HNW) individuals looking to build tax efficient Enterprise Investment Scheme (EIS) and Seed EIS portfolios;

· Family offices and private sector institutions;

· The Public Sector.

 

Investors can choose between investment types ranging from self-build portfolios, to a full fund management service.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPGUQCWUPCGMC
Date   Source Headline
29th Apr 20242:07 pmRNSHolding(s) in Company
29th Apr 20241:42 pmRNSBlock admission six monthly return
10th Apr 20247:00 amRNSHolding(s) in Company
27th Mar 202412:03 pmRNSHolding(s) in Company
6th Mar 20247:00 amRNSAcquisition of further interest in Autins Group
4th Mar 202411:48 amRNSInvestment update – Paraytec Limited
4th Mar 20247:00 amRNSCompletion of sale of Phasefocus
9th Jan 202412:00 pmRNSHolding(s) in Company
22nd Dec 20231:30 pmRNSHolding(s) in Company
22nd Dec 20237:00 amRNSPortfolio update - Proposed sale of Phasefocus
15th Dec 202311:41 amRNSInvestment update - Paraytec Limited
15th Dec 202310:16 amRNSReplacement: Half-year Report
14th Dec 20237:00 amRNSHalf-year Report
29th Nov 20237:00 amRNSInvestment update - Paraytec Limited
14th Nov 20239:02 amRNSHolding(s) in Company
17th Oct 20237:00 amRNSInvestment update – Paraytec Limited
10th Oct 202311:15 amRNSHolding(s) in Company
8th Sep 20237:00 amRNSInvestment update – Kirkstall Limited
8th Sep 20237:00 amRNSBlock admission six monthly return
21st Aug 20237:00 amRNSFurther investment in Phasefocus Holdings Limited
28th Jul 20232:25 pmRNSInvestment update on Paraytec Limited
28th Jul 202311:54 amRNSResult of AGM
5th Jul 20237:00 amRNSPosting of annual report and notice of AGM
4th Jul 20237:00 amRNSHolding(s) in Company
3rd Jul 20237:00 amRNSFinal Results for the year ended 31 March 2023
31st May 20237:00 amRNSInvestment update – Phasefocus Holdings Limited
3rd May 20237:00 amRNSUpdate on investments
24th Apr 202310:49 amRNSHolding(s) in Company
27th Mar 20237:00 amRNSGrant of options
13th Mar 20239:34 amRNSHolding(s) in Company
9th Mar 20237:00 amRNSBlock admission six monthly return
10th Feb 20231:26 pmRNSHolding(s) in Company
30th Jan 20234:37 pmRNSHolding(s) in Company
16th Jan 20237:00 amRNSDirector/PDMR Shareholding
10th Jan 20237:00 amRNSOperational update
22nd Dec 20229:14 amRNSHolding(s) in Company
19th Dec 20229:25 amRNSDirector/PDMR Shareholding
19th Dec 20229:11 amRNSAcquisition of interest in Image Scan Holdings plc
13th Dec 20224:37 pmRNSHolding(s) in Company
15th Nov 20223:09 pmRNSHolding(s) in Company
7th Nov 20227:00 amRNSDirector/PDMR Shareholding
28th Oct 20227:00 amRNSHalf-year Report
21st Oct 202210:33 amRNSHolding(s) in Company
20th Oct 20221:59 pmRNSAcquisition of further interest in Autins
5th Oct 20223:15 pmRNSHolding(s) in Company
5th Oct 202212:28 pmRNSAcquisition of further interest in Aukett Swanke
30th Sep 20225:00 pmRNSTotal Voting Rights
20th Sep 20227:00 amRNSPlacing and subscription to raise £750,000
9th Sep 20227:00 amRNSBlock admission six monthly return
6th Sep 20227:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.